Pharma Focus Europe

SeraNovo and Ildong Pharmaceutical to Collaborate on Research Projects

Tuesday, September 27, 2022

SeraNovo BV is excited to announce the successful completion of a multi-compound agreement with Ildong Pharmaceutical, a renowned pharmaceutical company based in Seoul, South Korea. Ildong Pharmaceutical focuses on the research and development of small molecules in the fields of neuroscience and oncology.

Niall Hodgins, the Chief Executive Officer of SeraNovo, expressed his satisfaction with the collaboration, stating, "SeraNovo has made significant strides in recent years, both in terms of our technical capabilities and global customer base. We are thrilled to share the news of this important partnership with such a prestigious company. Once again, our technology will play a crucial role in bringing essential therapies to patients. We eagerly anticipate a long and mutually beneficial relationship with Ildong.

magazine-slider-img
Thermo Fisher Scientific - mRNA ServicesWorld Orphan Drug Congress 2024World Vaccine Congress Europe 2024Advanced Therapies USA 2024
cytiva